Methods |
Women 'randomly allocated' into 3 groups. Method of randomisation not reported |
Participants |
360 women attending the family planning clinics in Chengwu (a county in Shandong), China. Women had regular menstrual periods and attended the clinic within 72 h of a single act of unprotected intercourse |
Interventions |
Mife 25 mg orally, 2 doses, 12 h apart vs Mife 10 mg, for 5 days vs Mife 10 mg, for 3 days |
Outcomes |
Observed number of pregnancies, side effects and changes in menstrual pattern |
Notes |
Post‐randomisation exclusion and loss to follow‐up not reported
Observed pregnancy/expected pregnancy/total number of women: Mife 25 mg twice 2/13/120; Mife 10 mg qd/5 days 0/12/118; Mife 10 mg qd/3 days 1/11/116
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Mentioned randomisation but description not adequate |
Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment not mentioned |
Blinding (performance bias and detection bias) All outcomes |
Unclear risk |
Not mentioned |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk |
Post‐randomisation exclusion and loss to follow‐up not reported |
Selective reporting (reporting bias) |
Low risk |
Reported planned outcomes |
Other bias |
Low risk |
None detected |